Zobrazeno 1 - 5
of 5
pro vyhledávání: '"D P, Modest"'
Autor:
G. Sommerhäuser, A. Kurreck, S. Stintzing, V. Heinemann, L. Fischer von Weikersthal, T. Dechow, F. Kaiser, M. Karthaus, I. Schwaner, M. Fuchs, A. König, C. Roderburg, I. Hoyer, M. Quante, A. Kiani, S. Fruehauf, L. Müller, A. Reinacher-Schick, T. J. Ettrich, A. Stahler, D. P. Modest
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Initial systemic therapy for patients with metastatic colorectal cancer (mCRC) is usually based on two- or three-drug chemotherapy regimens with fluoropyrimidine (5-fluorouracil (5-FU) or capecitabine), oxaliplatin and/or irinotec
Externí odkaz:
https://doaj.org/article/d871b783250b4f5bb8603eb81bc83942
Publikováno v:
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 91(5)
Liver metastases represent the most common secondary malignant liver disease. Data regarding the incidence of colorectal and non-colorectal liver metastases are rare due to insufficient documentation in a register. Results regarding neoadjuvant thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f32e7cb583e4d68c3e27dd126a27e828
https://pubmed.ncbi.nlm.nih.gov/32291472
https://pubmed.ncbi.nlm.nih.gov/32291472
Autor:
A, Stahler, V, Heinemann, C, Giessen-Jung, A, Crispin, A, Schalhorn, S, Stintzing, L, Fischer von Weikersthal, U, Vehling-Kaiser, M, Stauch, D, Quietzsch, S, Held, J C, von Einem, J, Holch, J, Neumann, T, Kirchner, A, Jung, D P, Modest
Publikováno v:
International journal of cancer. 138(3)
Our aim was to investigate the impact of EREG and AREG mRNA expression (by RT-qPCR) in patients with metastatic colorectal cancer (mCRC). In addition, epidermal growth factor receptor (EGFR) expression (by immunohistochemistry) as well as RAS-and PIK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::259694515aeb7082064b6743b34bc80f
https://pubmed.ncbi.nlm.nih.gov/26284333
https://pubmed.ncbi.nlm.nih.gov/26284333
Publikováno v:
Der Internist. 55(1)
Increasing numbers of therapeutic options are becoming available for the systemic treatment of metastasized colorectal cancer (mCRC) which emphasizes the need for strategic decision making and planning across multiple lines of treatment. The choice o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c823d0d6d27f493cbe7a1f8e5122198b
https://pubmed.ncbi.nlm.nih.gov/24399471
https://pubmed.ncbi.nlm.nih.gov/24399471
Autor:
S, Gamba, Y, Zhao, L, Zhao, Y, Wang, B, Schwarz, S, Primo, K-W, Jauch, P J, Nelson, D P, Modest, H, Nieß, C, Bruns
Publikováno v:
Zentralblatt fur Chirurgie. 140(3)
In this review we summarise the recent developments regarding the experimental and clinical use of mesenchymal stem cells (MSCs), focusing mainly on the treatment of gastrointestinal disorders. Next to their relevance in the field of regenerative med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1c4ba1ac8b5bd52751d5860920164111
https://pubmed.ncbi.nlm.nih.gov/23836276
https://pubmed.ncbi.nlm.nih.gov/23836276